All Categories

Last week, The NemetzGroup team met (virtually, of course!) to share insights from 2021 and how we could make 2022 even better. We broke into small Zoom groups, each of which was given 10 minutes to brainstorm on four topics:

In a recent internal planning session for Corval, our new cloud-based commercialization planning platform, we debated whether the term “Freedom to Lead” would resonate with our audience of early- to mid-stage biopharma companies. 

As we emerge, slowly, into a new phase of the pandemic, there are many “thought bubbles” popping up — viewpoints, concerns, and ideas that we share with others or keep to ourselves as we try to manage the present and anticipate the future.